10/11/2025
🌍 Future health crises can be prevented by making full use of science.
At Ceva, we believe that innovative technologies enable us to design and produce the vaccines of the future to combat emerging diseases. With , our new genomic research platform in Beaucouzé (France), we are committed to addressing the challenges posed by the rise of new epizootics by developing effective, industrialised, and competitive vaccine solutions capable of rapidly responding to emerging infectious diseases.
This ambitious project, supported by the French government and the Pays de la Loire Region, brings together exceptional partners such as Cirad - La recherche agronomique pour le développement and CEA. With this investment, Ceva confirms its leadership in animal health research and innovation, as well as its commitment to the concept.
This new platform is equipped with cutting-edge technological innovations, incorporating the latest high-throughput sequencing and bioinformatics techniques for developing nucleotide vaccines. The site features a centralised bioinformatics interface that facilitates the detailed analysis and processing of large volumes of vaccine data (coverage, efficacy, antigen design, etc.).
Discover more about our new genomics research laboratory 👉 https://loom.ly/-POZ44g
fans